ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 137 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 8.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,962,000 | +25.7% | 124,177 | +1.0% | 0.07% | +39.6% |
| Q1 2018 | $1,561,000 | -61.4% | 122,900 | -65.2% | 0.05% | -54.7% |
| Q4 2017 | $4,043,000 | -25.1% | 353,100 | -19.8% | 0.12% | -34.3% |
| Q3 2017 | $5,396,000 | +260.2% | 440,488 | +871.2% | 0.18% | -13.2% |
| Q4 2015 | $1,498,000 | +20.3% | 45,355 | +19.4% | 0.20% | +632.1% |
| Q3 2015 | $1,245,000 | -55.9% | 38,000 | -28.8% | 0.03% | -62.2% |
| Q2 2015 | $2,826,000 | +136.5% | 53,358 | +28.9% | 0.07% | +146.7% |
| Q1 2015 | $1,195,000 | +236.6% | 41,400 | +239.3% | 0.03% | -14.3% |
| Q4 2014 | $355,000 | +116.5% | 12,202 | -5.5% | 0.04% | +775.0% |
| Q3 2014 | $164,000 | – | 12,914 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |